Mechanistically, cytoplasmic precursor CLU binds ROCK1 to decrease the phosphorylation of ERK1/2 by inhibiting the kinase activity of ROCK1, leading to an anti-metastatic effect in lung cancer cells. Here, MAPK3 is linked to lung cancer.